Paras Medical Agency Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-07-2024
- Paid Up Capital ₹ 5.00 M
as on 18-07-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.82 Cr
as on 18-07-2024
- Satisfied Charges ₹ 1.70 Cr
as on 18-07-2024
- Revenue 1.09%
(FY 2023)
- Profit 33.58%
(FY 2023)
- Ebitda 26.92%
(FY 2023)
- Net Worth 11.90%
(FY 2023)
- Total Assets -1.45%
(FY 2023)
About Paras Medical Agency
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹26.82 Cr. The company has closed loans amounting to ₹1.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aruna Chopra and Mahendrakumar Chopra serve as directors at the Company.
- CIN/LLPIN
U51109MH2011PTC212761
- Company No.
212761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Dombivli East, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Paras Medical Agency?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aruna Chopra  | Director | 27-Jan-2011 | Current |
| Mahendrakumar Chopra | Director | 27-Jan-2011 | Current |
Financial Performance of Paras Medical Agency.
Paras Medical Agency Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.09% increase. The company also saw a substantial improvement in profitability, with a 33.58% increase in profit. The company's net worth Soared by an impressive increase of 11.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paras Medical Agency?
In 2022, Paras Medical Agency had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 08 Feb 2021 | ₹8.20 M | Open |
Axis Bank Limited Creation Date: 10 Aug 2015 | ₹16.00 Cr | Open |
Axis Bank Limited Creation Date: 17 Jun 2015 | ₹10.00 Cr | Open |
How Many Employees Work at Paras Medical Agency?
Paras Medical Agency has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paras Medical Agency, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paras Medical Agency's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
